Transtorno de ansiedade generalizada e tratamento com canabidiol: um relato de caso

• Autor(a) principal: Silva, Monique Conceição Martins Alves da
• Data de Publicação: 2021
• Tipo de documento: Trabalho de conclusão de curso
• Idioma: por
• Título da fonte: Repositório do Centro Universitário Braz Cubas
• Texto Completo: https://repositorio.cruzeirodosul.edu.br/handle/123456789/2876
• topic: Transtorno de ansiedade generalizada; Cannabis; Canabidiol; CNPQ::CIENCIAS DA SAUDE::MEDICINA

Introduction: This Course Completion Work discusses Generalized Anxiety Disorder (GAD) characterized by excessive and persistent concerns, accompanied by physical symptoms such as muscle tension, insomnia, difficulty concentrating, fatigue, sweating. Concerns are widespread, without triggers, and difficult to control. Traditional treatment consists of the use of benzodiazepines, antidepressants that inhibit serotonin reception and Cognitive Behavioral Therapy. Cannabidiol has been pointed out as an anxiolytic substance in the treatment of anxiety disorders, with studies showing a positive result in reducing anxiety, without increasing sedation. Objective: To report a clinical case of GAD in adult patient undergoing treatment with cannabidiol. Materials and methods: This are a case study, according to the CARE guidelines, of an observational nature, carried out in a Family Health Clinic in the city of João Pessoa, with a sample of male individual being monitored for the treatment of GAD. Digitalized medical record data were collected, extracting information about the symptoms and their chronology, previous medical consultations related to the problem, history of classic medications, when the GAD was diagnosed, beginning of therapy alternative, dose management, possible side effects, disease progression with the use cannabidiol, concomitant use of traditional medication while starting to use CBD, social relationships of the patient, whether these relationships imply in their disease or if the disease interferes with their social dynamics, psychological counseling is carried out. The study is in accordance with Resolution 466/2012 of the National Health Council and the patient will sing the Informed Consent Form (ICF) before participating in the research. Case report: Male patient, 28 years old, with generalized anxiety disorder, diagnosed in 2018, using 1% cannabidiol. Conclusion: From the present report, it is possible to perceive the possibility of treating in an unconventional way, showing cannabidiol as a potential therapeutic alternative.